Cargando…

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer

OBJECTIVE: Gynecologic cancers are associated with a high risk of venous thromboembolism (VTE). The Khorana score is a validated tool to assess risk of VTE in cancer patients. The purpose of this study is to determine if the Khorana score can be used as a risk stratification tool for VTE in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piver, Rachael N., Wagner, Vincent M., Levine, Monica D., Backes, Floor J., Chambers, Laura J., Cohn, David E., Copeland, Larry J., Cosgrove, Casey M., Nagel, Christa I., O'Malley, David M., Bixel, Kristin L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995928/ https://www.ncbi.nlm.nih.gov/pubmed/36910448 http://dx.doi.org/10.1016/j.gore.2023.101156

Ejemplares similares

High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors
por: Calo, Corinne A., et al.
Publicado: (2022)

Wound complications following vulvar excision for nonmalignant lesions
por: Boyles, Glenn P., et al.
Publicado: (2021)

Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly population
por: Haight, Paulina J, et al.
Publicado: (2023)

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
por: Sanfilippo, Kristen M., et al.
Publicado: (2022)

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
por: Akasaka-Kihara, Fumie, et al.
Publicado: (2021)

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
por: Mulder, Frits I., et al.
Publicado: (2019)

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
por: Overvad, Thure Filskov, et al.
Publicado: (2022)

Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
por: Rupa-Matysek, Joanna, et al.
Publicado: (2017)

Retrospective Cohort Study of Venous Thromboembolism Rates in Ambulatory Cancer Patients: Association With Khorana Score and Other Risk Factors
por: Austin, Keziah, et al.
Publicado: (2019)

Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
por: Choi, Yeo Jin, et al.
Publicado: (2021)

Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer
por: Riedinger, Courtney J., et al.
Publicado: (2023)

Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies
por: Ramos-Esquivel, Allan, et al.
Publicado: (2022)

Har Gobind Khorana (1922–2011): Pioneering Spirit
por: Sakmar, Thomas P.
Publicado: (2012)

Expression systems for bovine rhodopsin: a review of the progress made in the Khorana laboratory
por: Reeves, Philip J.
Publicado: (2023)

Validation of the Khorana Score to Assess Venous Thromboembolism and Its Association with Mortality in Cancer Patients: A Retrospective Community-based Observational Experience
por: Ahmed, Gulrayz, et al.
Publicado: (2020)

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial
por: Barni, Sandro, et al.
Publicado: (2020)

OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
por: López Jiménez, C., et al.
Publicado: (2021)

Corrigendum to “Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial”
Publicado: (2020)

Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
por: Khorana, Alok A., et al.
Publicado: (2020)

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma
por: Vathiotis, Ioannis, et al.
Publicado: (2018)

Learning from Gobind Khorana: “The difficult we do today, the impossible tomorrow”
por: Subramaniam, Sriram
Publicado: (2022)

An investigation into human papillomavirus (HPV) vaccination for patients undergoing surgery for high-grade cervical or vulvar dysplasia
por: Boyles, Glenn P., et al.
Publicado: (2022)

Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data
por: Tsubata, Yukari, et al.
Publicado: (2022)

Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience
por: Mirza, Abu-Sayeef, et al.
Publicado: (2019)

My remembrances of H.G. Khorana: exploring the mechanism of bacteriorhodopsin with site-directed mutagenesis and FTIR difference spectroscopy
por: Rothschild, Kenneth J.
Publicado: (2023)

Evaluation of the Khorana Predictive Thrombotic Risk and Thromboprophylaxis Score in Cancer Patients in a Third Level Hospital
por: Bermejo, Lara Almudena Fernández, et al.
Publicado: (2022)

Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
por: Ha, Hyerim, et al.
Publicado: (2023)

S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023)

The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study
por: Overvad, Thure F., et al.
Publicado: (2022)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
por: Lodetti, Giorgia, et al.
Publicado: (2023)

Clinical trials, adaptability and the COVID-19 pandemic
por: Eskander, Ramez N., et al.
Publicado: (2020)

Association between the Khorana risk score and all-cause mortality in Japanese patients with gastric and colorectal cancer: A retrospective cohort study
por: Zhang, Yu-Feng, et al.
Publicado: (2023)

Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019
por: Vetter, Monica Hagan, et al.
Publicado: (2020)

Case series of seven women with uterine fibroids associated with venous thromboembolism and chronic thromboembolic disease
por: Lacharite-Roberge, Anne-Sophie, et al.
Publicado: (2018)

Uterine Factor Infertility, a Systematic Review
por: Sallée, Camille, et al.
Publicado: (2022)

Biophysical Reviews contribution call: an issue focus on the life and works of Prof. Har Gobind Khorana on the occasion of the 100th anniversary of the year of his birth
por: Aradhyam, Gopala Krishna, et al.
Publicado: (2022)

Patient Satisfaction With Venous Thromboembolism Treatment
por: Webb, David, et al.
Publicado: (2019)

Acute worsening of dermatomyositis after initiation of PARP inhibitor therapy in two women with advanced ovarian malignancy
por: Graves, Stephen M., et al.
Publicado: (2021)

Do Not Forget about Hormonal Therapy for Recurrent Endometrial Cancer: A Review of Options, Updates, and New Combinations
por: Wagner, Vincent M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_56ug48fs0pe17ooh6k6u0dahet